Cover Image
Market Research Report

North America Automated Microbiology Market for over 100 Tests: Canada, Mexico, USA-Supplier Shares & Strategies, Volume & Sales Segment Forecasts for 100 Molecular, Identification, Susceptibility, Blood Culture, Urine Screening

Published by Venture Planning Group Product code 509954
Published Content info 455 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Automated Microbiology Market for over 100 Tests: Canada, Mexico, USA-Supplier Shares & Strategies, Volume & Sales Segment Forecasts for 100 Molecular, Identification, Susceptibility, Blood Culture, Urine Screening
Published: Content info: 455 Pages
Description

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 3-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Canada, Mexico, USA

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 455 pages and 108 tables

Table of Contents
Product Code: VP42455

Table of Contents

I. Introduction

II. Automated Microbiology Market Business Environment

III. New Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Market and Technology Overview

  • A. Introduction
    • 1. Major Factors Affecting Market Penetration for Microbiology Instrumentation
    • 2. Traditional Practices
    • 3. Technological Challenges
    • 4. Automation: Impact on the Microbiology Laboratory and the Patient
  • B. Major Specimen Types
    • 1. Urine
    • 2. Sterile Fluids: Blood, Serum, and CSF
    • 3. Throat Swabs and Respiratory Secretions
    • 4. Genital Secretions
    • 5. Stool
    • 6. Abscess/Wound
    • 7. Sputum
    • 8. Saliva
  • C. Test Applications
    • 1. Microbial Identification
    • 2. Antibiotic Susceptibility
    • 3. Urine Screening
      • a. Photometry
      • b. Bioluminescence
      • c. Colorimetric Filtration
      • d. Enzymatic Detection
      • e. Optical Detection
    • 4. Blood Cultures
  • D. Major Automated and Semi-automated Microbiology Systems
    • 1. Multiple Purpose Microbiology Systems
    • 2. Specialized Microbiology Systems
    • 3. Molecular Diagnostic Systems
    • 4. Immunodiagnostic Systems
  • E. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      • a. DNA Sequencing
      • b. DNA and RNA Probe Technologies
      • c. Detection Technologies
      • d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VIII. Country Analyses: Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests, Supplier Shares

  • - Canada
  • - Mexico
  • - USA

IX. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode
  • Diadexus
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Lonza
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan
  • Wallac/PE
  • Wako

List of Tables

  • Canada
  • Microbiology Specimen Volume Forecast by Type
  • Canada
  • Microbiology Test Volume Forecasts by Application
  • Canada
  • Microbiology Consumables Market Forecast by Application
  • Canada
  • Infectious Disease Test Volume Forecast by Assay
  • Canada
  • Infectious Disease Diagnostics Market Forecast by Test
  • Canada
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Canada
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Mexico
  • Microbiology Specimen Volume Forecast by Type
  • Mexico
  • Microbiology Test Volume Forecasts by Application
  • Mexico
  • Microbiology Consumables Market Forecast by Application
  • Mexico
  • Infectious Disease Test Volume Forecast by Assay
  • Mexico
  • Infectious Disease Diagnostics Market Forecast by Test
  • Mexico
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Mexico
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • U.S.A.
  • Laboratories Performing Microbiology Tests by Market Segment
  • U.S.A.
  • Hospital Laboratories Performing Microbiology Tests by Bed Size
  • U.S.A.
  • Commercial/Private Laboratories Performing Microbiology
  • Tests by Annual Test Volume
  • U.S.A.
  • All Market Segments Microbiology Specimen Volume
  • U.S.A.
  • Hospital Laboratories Microbiology Specimen Volume
  • U.S.A.
  • Physician Offices/Group Practices Microbiology Specimen Volume
  • U.S.A.
  • Public Health Laboratories Microbiology Specimen Volume
  • U.S.A.
  • Commercial/Private Laboratories Microbiology Specimen Volume
  • U.S.A.
  • Microbiology Test Volume by Market Segment
  • U.S.A.
  • Microbiology Test Volume by Application
  • U.S.A.
  • Microbial Identification Test Volume by Market Segment
  • U.S.A.
  • Urine Screening Test Volume by Market Segment
  • U.S.A.
  • Blood Culture Test Volume by Market Segment
  • U.S.A.
  • Antibiotic Susceptibility Test Volume by Market Segment
  • U.S.A.
  • Microbiology Consumables Market by Application
  • U.S.A.
  • Microbiology Consumables Market by Market Segment
  • U.S.A.
  • Microbial Identification Consumables Sales by Market Segment
  • U.S.A.
  • Antibiotic Susceptibility Consumables Sales by Market Segment
  • U.S.A.
  • Blood Culture Consumables Sales by Market Segment
  • U.S.A.
  • Urine Screening Consumables Sales by Market Segment
  • U.S.A.
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • U.S.A.
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Test
  • U.S.A.
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • U.S.A.
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • U.S.A.
  • HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Influenza Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Tuberculosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Molecular Diagnostics Market Sales and Shares of Major Suppliers
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top